Three composite adults with nausea, three routes into the brainstem and three receptor families: NU559's Unit 1 post holds that the route, not the symptom, picks the drug class. Searches like "nu 559 unit 1 assignment example", "nu559 unit 1 sample" and "nu559 unit 1 example" land here.
Three Nauseas, Three Routes to the Brainstem: Why One Antiemetic Is Not Enough
NU559 · Unit 1 Discussion
Posted by [Student Name]
All three patients are composites; no real person is described.
Initial Post
Jordan, your claim is half right. [Ondansetron] works very well where serotonin carries the signal. But nausea arrives at the vomiting center in the brainstem by several routes, and a drug that blocks one route does little for the others (Hornby, 2001). Three patients on this week's clinic schedule show the difference.
The [34]-year-old planning five days on a sailboat. Her nausea will come through the inner ear. Motion signals from the vestibular apparatus travel to the vestibular nuclei and then to the vomiting center, relayed by histamine H1 and muscarinic acetylcholine receptors. Serotonin plays little part, so ondansetron has little to act on. The classes that help are antihistamines such as [meclizine] and antimuscarinics such as a [scopolamine] patch, each blocking the receptor on that relay, ideally applied before she leaves the dock.
The [58]-year-old on day one after [cisplatin]. Here two pathways run at once. In the first 24 hours, chemotherapy damages enterochromaffin cells in the gut, which release serotonin onto 5-HT3 receptors on vagal afferent fibers, and the signal travels up the vagus to the brainstem. That is ondansetron's textbook target. From about day two to day five, a delayed phase follows, carried largely by substance P acting on NK1 receptors in the brainstem. A serotonin blocker alone leaves the delayed phase uncovered, which is why an NK1 antagonist such as aprepitant joins the regimen for highly emetogenic chemotherapy. Guidelines combine a 5-HT3 antagonist, an NK1 antagonist and dexamethasone, often with olanzapine, for that reason (Navari & Aapro, 2016).
The [46]-year-old with diabetic gastroparesis. His stomach holds food too long, and distension signals travel up the vagus. The class used here, a dopamine D2 antagonist such as [metoclopramide], blocks D2 receptors in the chemoreceptor trigger zone and also promotes gastric emptying. The same mechanism carries a caution: dopamine blockade can reach the basal ganglia, causing movement disorders, including tardive dyskinesia with prolonged use, which is why its use is limited in duration (Camilleri et al., 2013).
So the pathway matters. Ondansetron is excellent where serotonin carries the signal and a poor choice where histamine, acetylcholine or dopamine do.
Reply to Jordan's Response
Jordan, you asked whether ondansetron could still help the sailor a little. Probably only slightly; trials of 5-HT3 antagonists for motion sickness have been disappointing, which fits the pathway. For her, the timing of the patch matters more than the choice of a second drug.
Reply to Priya
Priya, your point about ondansetron and the QT interval adds a fourth reason to choose by mechanism. For the gastroparesis patient, who may also be taking other QT-prolonging drugs, that makes an ECG worth checking before we reach for it as a backup.
References
Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L., & Gerson, L. (2013). Clinical guideline: Management of gastroparesis. American Journal of Gastroenterology, 108(1), 18-37. https://doi.org/10.1038/ajg.2012.373
Hornby, P. J. (2001). Central neurocircuitry associated with emesis. The American Journal of Medicine, 111(Suppl. 8A), 106S-112S. https://doi.org/10.1016/S0002-9343(01)00849-X
Navari, R. M., & Aapro, M. (2016). Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. New England Journal of Medicine, 374(14), 1356-1367. https://doi.org/10.1056/NEJMra1515442
How this NU559 Unit 1 example is structured
A claim, three tests of it and a conclusion that narrows the claim instead of refuting it: that is the architecture. The opening concession matters, because a board post that simply contradicts a peer reads as scoring a point. Each patient paragraph runs in the same order, route first, receptor second, drug class third, so a reader can compare them across the post. The chemotherapy paragraph is the longest, since two pathways run at once there: an early serotonin phase and a later one carried by substance P at NK1 receptors, which is why aprepitant joins the regimen. The gastroparesis paragraph adds a caution drawn from the same mechanism, dopamine blockade reaching the basal ganglia. References sit at the foot, a pharmacology text and one antiemetic guideline cited with its year. Replies follow the original post.
Get an NU559 Unit 1 example written to your instructions
A board sample for NU559 starts from what your section actually posted: the opening question, any classmate post you must answer, and whatever criteria grade the thread. Built around the condition that question anchors on, the returned post ties every drug class to its step and brackets each agent. A first request costs nothing and returns in 24-48h. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
NU559 Unit 1 questions, answered
Does the post need three patients, or would one condition do?
One condition often does, and many prompts name a single anchor. Three cases suit a question about how mechanism changes therapy because contrast makes the point visible: the same symptom, different routes, different classes. If your section limits length, two contrasting patients can carry the argument, provided each paragraph names the receptor involved and the drug class acting there.
Should drug names appear with doses in a board post?
Rarely. This course generally asks for classes and mechanisms, and a dose in a discussion post invites the question of whether it applies to anyone real. The sample names agents only as illustrations of a class and places them in brackets. If your prompt does ask for a regimen, cite the reference that supplied it rather than presenting it as your own recommendation.
How many sources does an opening post usually cite?
Two or three is common: the assigned pharmacology text, a pathophysiology text or review, and perhaps one guideline where a regimen is mentioned. Look for a minimum and a recency window in the rubric. A guideline listed without its year is a frequent small deduction, and a website summary standing in for the source it summarizes tends to cost more.